Parachute Biotech Solutions | Senior Biotech Consultancy

Parachute
is a New Kind
of Biotech Partner

Parachute Biotech Solutions is built by seasoned operators to challenge the conventional consulting model. We bring decades of real-world experience across biotech, pharma, and investment, working alongside your team rather than above it, to deliver control, clarity, and a safe landing when the stakes are highest.

We align investor confidence in your science with a clear, credible story, anchored in robust development and commercial planning and supported by an integrated execution plan that protects time, capital, and credibility.

Our model is designed to de-risk delivery, not to maximise billable hours.

Experienced Leaders. Embedded Execution. No Fluff.

The Biotech Reality

Early-stage biotech companies often enter critical development phases without fully integrated senior leadership. As programmes move into the clinic, execution risk increases, capital deployment accelerates, and gaps in planning, governance, and oversight become increasingly costly. Misalignment between clinical execution, operational readiness, and investor expectations can quickly erode momentum, credibility, timelines, and valuation.

We Close the Gap

Embedded senior leadership bringing control, clarity, and accountability to clinical and commercial execution.

Milestones planned, led, and communicated with confidence
Real clinical readiness aligned to investors and regulators
Outsourcing, delivery, and execution owned end-to-end
Development strategy and data translated into commercial value
Better planning protects time, capital, and valuation

What We Do

We provide senior, execution-focused leadership across commercialisation and corporate affairs, clinical development operations, medical and scientific affairs, regulatory affairs, quality assurance, organisational culture and governance.

Commercialisation & Asset Launch

Strategic asset commercialisation, portfolio management and value messaging for global markets

Investor & Public Relations

Specialised biotech investor relations, corporate communications, and visual storytelling for stakeholders

Organisational Operations

Strategic asset commercialisation, portfolio management and value messaging for global markets

Global Quality & Regulatory Strategy

Comprehensive support for dossier gap analysis, scientific advice, and inspection readiness

Clinical Development Operations

Expertise in programme leadership, translational medicine, and clinical study monitoring

Medical Leadership & Pharmacovigilance

Ensuring drug safety monitoring and medical scientific communications throughout development

Whether fractional or project-based, we fly in tandem with you, not as detached observers, aligning development execution with the milestones, governance, and narrative required to build company value.

How We Work

Aligning the story with the milestones and underpinning with an integrated delivery plan, protecting time, capital, and credibility.

In Tandem, Not Adjacent

Whether fractional or project-based, we fly in tandem with your team - not as detached observers.

Strategy, Data & Capital Aligned

Our cross-functional experts align strategy, data and capital markets so the story lands with investors and regulators.

Pressure-Tested, Controlled Delivery

We define the drop zone early, de-risk execution, and stay through delivery with calm, disciplined oversight.

Built for Outcomes, Not Activity

We integrate directly into teams and focus on what gets delivered, not hours billed or decks produced.

What Sets Us Apart

Parachute Biotech Solutions is built for delivery, not billable hours.

We exist to deploy, not to produce slides, bringing experienced, embedded leadership that works shoulder-to-shoulder with your team and takes real accountability for outcomes. We align clinical execution and investor narrative from the outset, ensuring your development plans, milestones, and external positioning move together with clarity and credibility. Our model is powered by trusted, high-performing networks across biotech, pharma, and investment, and grounded in clear thinking, early course correction, and disciplined execution. We challenge assumptions, reduce risk before it compounds, and operate with a no-nonsense, values-driven approach that respects time, capital, and the realities of building biotech companies.